Newsletter September 2017
We join friends and colleagues around the world to mark September 28th, International Safe Abortion Day. Abortion-related morbidity and mortality remain high due to restricted access, stigma, misinformation and lack of good services. Our work to improve access to safe abortion remains a top priority for Gynuity starting with involvement in seminal early research leading to mifepristone's approval in the U.S. We have decades of experience bringing medical abortion technology to women in many other countries, including technical input to international and national clinical guidelines. Our ongoing work includes service delivery innovations and support to governments and health systems to make evidence-based care available and within reach of all women. Our "Spotlight on..." feature focuses on second trimester abortion services which are often highly stigmatized and challenging for health systems. In addition to recognition of International Safe Abortion Day, we hope you will join us to celebrate the 17th anniversary of mifepristone registration in the United States. We appreciate your interest in our work and look forward to sharing more news in the months ahead.